The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial

1. Eron Jr., J.
2. Yeni, P.
3. Gathe Jr., J.
4. Estrada, V.
5. DeJesus, E.
6. Staszewski, S.
7. Lackey, P.
8. Katlama, C.
9. Young, B.
10. Yau, L.
11. Sutherland-Phillips, D.
12. Wannamaker, P.
13. Vavro, C.
14. Patel, L.
15. Yeo, J.
16. Shaefer, M.